Showing results (501-510 of 586) with videos related to

Sort By:
Pageof 59
European Heart Journal|October 18, 2013
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trialKenneth W Mahaffey, Susanna R Stevens, Harvey D White, et al.
American Heart Journal|August 25, 2015
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome modelsPrateeti Khazanie, Gretchen M Heizer, Vic Hasselblad, et al.
American Heart Journal|August 25, 2015
Diuretic response in acute heart failure-an analysis from ASCEND-HFJozine M ter Maaten, Allison M Dunning, Mattia A E Valente, et al.
American Heart Journal|November 2, 2013
Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trialRoberto Latini, Lidia Staszewsky, Jie-Lena Sun, et al.
Circulation|July 28, 2010
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or bothAnne-Catherine Pouleur, Ebrahim Barkoudah, Hajime Uno, et al.
Circulation|November 21, 2007
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trialPierluigi Tricoci, Yuliya Lokhnygina, Lisa G Berdan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2005
A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertensionTimothy J McMahon, Gregory S Ahearn, Martin P Moya, et al.
American Heart Journal|July 29, 2014
Independent data monitoring committees: preparing a path for the futureConnie N Hess, Matthew T Roe, C Michael Gibson, et al.
Heart (British Cardiac Society)|February 19, 2016
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxabanGünter Breithardt, Helmut Baumgartner, Scott D Berkowitz, et al.
European Journal of Heart Failure|March 2, 2006
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunctionLars Køber, Karl Swedberg, John J V McMurray, et al.
Pageof 59